Quest Diagnostics Set to Release First Quarter 2025 Financial Results on April 22

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the field of diagnostic information services, has announced its plans to release its financial results for the first quarter of 2025 on Tuesday, April 22, 2025. The announcement marks an important date for investors and stakeholders as the company prepares to disclose key financial metrics that could influence its stock performance and market perception.

The financial results will be made available before the market opens on April 22, 2025. Following the release, Quest Diagnostics will conduct a quarterly conference call at 8:30 a.m. Eastern Time to discuss the results in detail. This call presents an opportunity for analysts and investors to gain insights into the company's performance metrics, strategic initiatives, and future outlook.

Participants who wish to join the conference call can do so by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 for international callers, using the passcode "7895081." The company has advised participants to connect approximately 10 minutes prior to the start of the call to ensure a smooth experience.

In addition to the live conference call, Quest Diagnostics will make its earnings release available on their investor relations website at www.QuestDiagnostics.com/investor. Investors can also access a live webcast of the conference call through the same platform, allowing for a comprehensive understanding of the company's financial performance.

For those unable to participate in the live discussion, a replay of the call will be accessible online shortly after the event. The replay will be available until midnight Eastern Time on May 6, 2025, providing ample opportunity for stakeholders to catch up on the discussions.

Domestic callers can access the replay by dialing 866-361-4757, while international callers can reach it at 203-369-0183, with no passcode required.

Quest Diagnostics encourages all participants of the conference call to review the company’s periodic reports filed with the Securities and Exchange Commission. These documents contain discussions of risk factors, historical operations, and financial conditions that are crucial for a holistic understanding of the company's current standing and future potential.

Quest Diagnostics is dedicated to advancing healthcare outcomes through precise diagnostic insights derived from laboratory testing. With a vast database of clinical lab results, the company empowers individuals, physicians, and organizations to make informed health decisions. Serving one in three adult Americans and half of the physicians and hospitals across the United States, the company employs over 55,000 professionals who are committed to transforming lives through actionable health insights.

As the scheduled date approaches, stakeholders eagerly anticipate the insights and data that Quest Diagnostics will share, shedding light on the company's trajectory in the evolving healthcare landscape.